Skip to main content

Ortho Clinical Diagnostics Holdings plc

OCDXDelisted May 27, 2022
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001828443

Ortho Clinical Diagnostics Holdings plc was delisted on May 27, 2022; its insiders filed their last Form 4 on Jun 1, 2022; 170 institutions reported holding it in 13F filings for Q1 2022, worth $4.38B in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Ortho Clinical Diagnostics Holdings plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

OCDX is no longer listed, so this page shows Q1 2022. 13F filings for later quarters list far fewer holders.

Institutional holders
170
+8 vs. Q4 2021
Shares held
234.6M
+480.4K (+0.2%) vs. Q4 2021
Total value
$4.38B
−$629.4M (−12.6%) vs. Q4 2021
New holders
48
59 more added
Sold out
40
50 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OCDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 170 institutions
Q1 2021: 95 institutionsQ2 2021: 106 institutionsQ3 2021: 140 institutionsQ4 2021: 162 institutionsQ1 2022: 170 institutionsQ2 2022: 1 institutionQ3 2022: 1 institutionQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $4.38B
Q1 2021: $4.52BQ2 2021: $4.95BQ3 2021: $4.31BQ4 2021: $5.01BQ1 2022: $4.38BQ2 2022: $1.00KQ3 2022: $1.00KQ4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding OCDX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20221$1.00K
Q2 20221$1.00K
Q1 2022170$4.38B
Q4 2021162$5.01B
Q3 2021140$4.31B
Q2 2021106$4.95B
Q1 202195$4.52B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Ortho Clinical Diagnostics Holdings plc; share changes are against Q4 2021.

Institutions holding OCDX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
PDT Partners, LLC0$00.00%−18,734−100.0%Sold out
Brown Advisory Inc0$00.00%−14,994−100.0%Sold out
Ameriprise Financial Inc0$00.00%−14,945−100.0%Sold out
Blueshift Asset Management, LLC0$00.00%−13,355−100.0%Sold out
Advisory Research Inc0$00.00%−13,153−100.0%Sold out
Federated Hermes, Inc.0$00.00%−4,202−100.0%Sold out
State of Wyoming0$00.00%−2,577−100.0%Sold out
Wolverine Asset Management LLC0$00.00%−1,000−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−128−100.0%Sold out
CWM, LLC0$00.00%−7−100.0%Sold out